Status:
COMPLETED
A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients
Lead Sponsor:
MEDA Pharma GmbH & Co. KG
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of the study is to compare effectiveness and safety of multiple applications of imiquimod 5% cream and vehicle cream in graft recipients suffering from actinic keratosis.
Eligibility Criteria
Inclusion
- Have a total of 4-10 actinic keratosis (AK) lesions located on either face or scalp
- If female and of childbearing potential, have a negative urine pregnancy test at treatment initiation, and willing to use a medically acceptable method of contraception during the treatment period
- Renal, liver or heart transplant recipients
Exclusion
- Graft rejection with loss of the graft in the medical history
- Unstable status of organ transplant disease during the last 12 months
- Known to be pregnant or lactating
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00189267
Start Date
November 1 2002
End Date
September 1 2005
Last Update
February 7 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.